ArticleClinical drug investigation2006
Prevalence of methylphenidate use among Israeli children: 1998-2004.
Article in Clinical drug investigation, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
18 citing papers in PubMed.
- Prevalence of use of on-label and off-label psychotropics in the Greek pediatric population.Frontiers in pharmacology · 2024Article
- Utilisation of drugs for the treatment of psychiatric diseases in the pediatric population: focus on off-label use.Frontiers in pharmacology · 2023Article
- Trends in the Prevalence of Chronic Medication Use Among Children in Israel Between 2010 and 2019: Protocol for a Retrospective Cohort Study.JMIR research protocols · 2022Article
- Overdiagnosis of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: A Systematic Scoping Review.JAMA network open · 2021Article
- Stimulant use for ADHD and relative age in class among children in Israel.Pharmacoepidemiology and drug safety · 2016Article
- Psychotropic medicine prescriptions in Italian youths: a multiregional study.European child & adolescent psychiatry · 2016Article
- Differences in ADHD medication usage patterns in children and adolescents from different cultural backgrounds in the Netherlands.Social psychiatry and psychiatric epidemiology · 2015Article
- Association between ADHD drug use and injuries among children and adolescents.European child & adolescent psychiatry · 2014Article
- The effect of alpha-linolenic acid supplementation on ADHD symptoms in children: a randomized controlled double-blind study.Frontiers in human neuroscience · 2014Article
- Comorbidities in ADHD children treated with methylphenidate: a database study.BMC psychiatry · 2013Article
- Lisdexamfetamine dimesylate: a new therapeutic option for attention-deficit hyperactivity disorder.CNS drugs · 2012Review
- Article
- Long-term outcomes with medications for attention-deficit hyperactivity disorder: current status of knowledge.CNS drugs · 2011Review
- Less discontinuation of ADHD drug use since the availability of long-acting ADHD medication in children, adolescents and adults under the age of 45 years in the Netherlands.Attention deficit and hyperactivity disorders · 2010Article
- The changing prevalence of attention-deficit/hyperactivity disorder and methylphenidate prescriptions: a study of data from a random sample of insurees of the AOK Health Insurance Company in the German State of Hesse, 2000-2007.Deutsches Arzteblatt international · 2010Article
- Prevalence and patterns of methylphenidate use in French children and adolescents.European journal of clinical pharmacology · 2008Article
- Review
- Prevalence of methylphenidate use among Canadian children following parental divorce.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2007Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundUse of methylphenidate for the treatment of attention-deficit hyperactivity disorder (ADHD) has increased throughout the world in the past decade. In Israel, as elsewhere, there is much debate regarding the diagnosis of ADHD and methylphenidate use. The aim of this study was to examine methylphenidate use rates for the treatment of ADHD among children in Israel during the years 1998-2004 with a special focus on prescriptions among girls. STUDY DESIGN AND
methodsThis was a longitudinal population-based prevalence study wherein we reviewed the computerised database of a major health maintenance organisation (HMO). Subjects studied included all children living in the central district of Clalit HMO in Israel who were prescribed methylphenidate in the 7-year period from 1998-2004. MAIN OUTCOME MEASURES AND
resultsThe overall 1-year prevalence rate of methylphenidate use in children aged 0-18 years increased from 0.7% in 1998 to 2.5% in 2004, an increase by a factor of 3.54 (95% CI 3.31, 3.79). In 1998, the rate of methylphenidate prescription ranged from 0.20% among schoolgirls to 1.2% among boys, a 6-fold difference. In 2004, the rate of methylphenidate prescription ranged from 1.1% among schoolgirls to 3.8% among boys; the sex difference had narrowed to only 3.45. Except for kindergarten girls, methylphenidate utilisation increased for all ages from kindergarten to high school, both among boys and among girls.
conclusionThe continuous increasing rate of methylphenidate use in Israel, especially among girls, represents a significant public health issue. There is a need for future research into the relationship between sex and ADHD diagnosis and treatment.
Indexed as
Identifiers
17163247What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.